Global Pet Diabetes Care Industry: Key Statistics and Insights in 2024-2032
Summary:
- The global pet diabetes care market size reached USD 2.0 Billion in 2023.
- The market is expected to reach USD 3.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.77% during 2024-2032.
- North America leads the market, accounting for the largest pet diabetes care market share.
- The market outlook is improving. It's due to the rise of AI and ML in diagnosing and treating diabetes in pets.
- These technologies are being used to create algorithms and predictive models that efficiently track and evaluate pet health data, resulting in the early identification of diabetes.
- AI-driven platforms provide real-time insights into pet health. They process vast data from multiple sources, including glucose monitors.
- This method improves diabetes care. It predicts health problems and suggests treatment changes. AI and ML improve pets' lives by enabling quick treatment for diabetes.
Industry Trends and Drivers:
- Increasing Prevalence of Pet Obesity:
Domestic animals, especially cats and dogs, are increasingly leading lifestyles that contribute to overweight and obesity, raising their risk of developing diabetes mellitus. Poor diets, lack of exercise, and genetics are increasing diabetes in pets. As a result, vets are seeing more cases. These require special care, monitoring, and treatment. There is a growing demand for specialized products and services that care for diabetes in pets, such as glucose monitors, insulin therapies, and dietary management solutions. This need for comprehensive care strategies to manage pet diabetes is driving market growth.
- Advancements in Veterinary Healthcare Technology:
The management of diabetes in pets is improving. New tests and treatments are being discovered and used. Accurate, real-time glucose monitoring is now possible. Innovations like pet CGMs and simple insulin devices made it so. These technologies boost the quality of life for diabetic pets and ease care for vets and owners. Meanwhile, telemedicine and health apps enhance disease management and prevention, enabling early diagnosis and treatment.The industry is expanding. Ongoing research aims to improve medicines and find new therapies.
- Growing Awareness and Pet Parent Education:
Growing awareness of health issues, especially diabetes, is boosting the market. Pet owners are more educated about these conditions. Veterinary professionals and pet care groups are educating pet owners on diabetes in animals. They are focusing on its symptoms, risks, and treatment. This greater awareness is leading to more informed pet health decisions, such as regular veterinary check-ups, food adjustments, and early intervention plans. As pet parents become more aware of the necessity of early detection and efficient diabetes management, the demand for specialized care items and services—such as nutritional solutions, insulin therapy, and pet-specific monitoring devices—increases.
Grab a sample PDF of this report: https://www.imarcgroup.com/pet-diabetes-care-market/requestsample
Pet Diabetes Care Market Report Segmentation:
By Solution:
- Treatment
- Glucose Monitoring Devices
Treatment exhibits a clear dominance in the market. It directly addresses the immediate health needs of pets with diabetes, including insulin therapy and monitoring equipment.
By Animal Type:
- Dogs
- Cats
Dogs represent the largest segment due to their higher predisposition to diabetes compared to other pets.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America dominates the market owing to high pet adoption rates, greater awareness about pet health issues, and the availability of advanced veterinary healthcare infrastructure.
Top Pet Diabetes Care Market Leaders:
The pet diabetes care market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:
- ACON Laboratories Inc.
- Allison Medical Inc.
- Becton Dickinson and Company
- Boehringer Ingelheim International GmbH
- i-SENS Inc.
- Merck & Co. Inc.
- Trividia Health Inc. (Sinocare)
- UltiMed Inc.
- Zoetis Inc
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145